Cogent Biosciences
IPOPublic · Boulder, United States · Founded 2016
- Headquarters
- Boulder, Colorado
- Employees
- 51–200
- Founded
- 2016
- Business Model
- B2B
- Website
- cogentbio.com
- Type
- Public
About
Clinical-stage biotech developing precision therapies for genetically defined diseases, focused on rational drug design.
Summary
Cogent Biosciences is a Biotech company based in Boulder, United States, founded in 2016. Investors include Commodore Capital, Fairmount Funds and Redmile Group.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Nov 2025
Sign up to see all 4 rounds
IPO through Secondary Market — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/cogent-biosciences"><img src="https://indexed.vc/api/badge/company/cogent-biosciences" alt="Cogent Biosciences on Indexed.vc" width="260" height="76" /></a>